Attempts to combine 2-deoxyglucose autoradiography and tyrosine hydroxylase immunohistochemistry

Integrating the Roles of Midbrain Dopamine Circuits in Behavior and Neuropsychiatric Disease

Dopamine (DA) is a behaviorally and clinically diverse neuromodulator that controls CNS function. DA plays major roles in many behaviors including locomotion, learning, habit formation, perception, and memory processing. Reflecting this, DA dysregulation produces a wide variety of cognitive symptoms seen in neuropsychiatric diseases such as Parkinson’s, Schizophrenia, addiction, and Alzheimer’s disease. Here, we review recent advances in the DA systems neuroscience field and explore the advancing hypothesis that DA’s behavioral function is linked to disease deficits in a neural circuit-dependent manner. We survey different brain areas including the basal ganglia’s dorsomedial/dorsolateral striatum, the ventral striatum, the auditory striatum, and the hippocampus in rodent models. Each of these regions have different reported functions and, correspondingly, DA’s reflecting role in each of these regions also has support for being different. We then focus on DA dysregulation states in Parkinson’s disease, addiction, and Alzheimer’s Disease, emphasizing how these afflictions are linked to different DA pathways. We draw upon ideas such as selective vulnerability and region-dependent physiology. These bodies of work suggest that different channels of DA may be dysregulated in different sets of disease. While these are great advances, the fine and definitive segregation of such pathways in behavior and disease remains to be seen. Future studies will be required to define DA’s necessity and contribution to the functional plasticity of different striatal regions.

The hypothalamus and periaqueductal gray are the sources of dopamine fibers in the paraventricular nucleus of the thalamus in the rat

The paraventricular nucleus of the thalamus (PVT) sends a very dense projection to the nucleus accumbens. This area of the striatum plays a key role in motivation and recent experimental evidence indicates that the PVT may have a similar function. It is well known that a dopaminergic projection from the ventral tegmental area (VTA) to the nucleus accumbens is a key regulator of motivation and reward-related behavior. Dopamine (DA) fibers have also been localized in the PVT but the source of these fibers in the rat has not been unequivocally identified. The present study was done to re-examine this question. Small iontophoretic injections of cholera toxin B (CTb) were made in the PVT to retrogradely label tyrosine hydroxylase (TH) neurons. Neurons that were double-labeled for TH/CTb were found scattered in DA cell groups of the hypothalamus (ventrorostral A10, A11, A13, A15 DA cell groups) and the midbrain (dorsocaudal A10 embedded in the periaqueductal gray). In contrast, double-labeled neurons were absent in the retrorubral field (A8), substantia nigra (A9) and VTA (A10) of the midbrain. We conclude that DA fibers in the PVT do not originate from VTA but from a heterogeneous population of DA neurons located in the hypothalamus and periaqueductal gray.

The time-course of hindbrain neuronal activity varies according to location during either intraperitoneal or subcutaneous tumor growth in rats: single Fos and dual Fos/dopamine β-hydroxylase immunohistochemistry

Neuronal activity in the nucleus of the solitary tract, ventrolateral medulla, area postrema, and parabrachial nucleus was studied in rats with intraperitoneal or subcutaneous tumors on the 7th, 14th, 21st, and 28th day after injection of fibrosarcoma tumor cells. We found that the number of Fos and dopamine β-hydroxylase immunopositive neurons differs between animals with intraperitoneal and subcutaneous tumors and also between tumor-bearing rats at different times following injection. Our data indicate that responses of the brainstem structures to peripheral tumor growth depend on the localization as well as the stage of the tumor growth.

Fueling and imaging brain activation

Metabolic signals are used for imaging and spectroscopic studies of brain function and disease and to elucidate the cellular basis of neuroenergetics. The major fuel for activated neurons and the models for neuron–astrocyte interactions have been controversial because discordant results are obtained in different experimental systems, some of which do not correspond to adult brain. In rats, the infrastructure to support the high energetic demands of adult brain is acquired during postnatal development and matures after weaning. The brain's capacity to supply and metabolize glucose and oxygen exceeds demand over a wide range of rates, and the hyperaemic response to functional activation is rapid. Oxidative metabolism provides most ATP, but glycolysis is frequently preferentially up-regulated during activation. Underestimation of glucose utilization rates with labelled glucose arises from increased lactate production, lactate diffusion via transporters and astrocytic gap junctions, and lactate release to blood and perivascular drainage. Increased pentose shunt pathway flux also causes label loss from C1 of glucose. Glucose analogues are used to assay cellular activities, but interpretation of results is uncertain due to insufficient characterization of transport and phosphorylation kinetics. Brain activation in subjects with low blood-lactate levels causes a brain-to-blood lactate gradient, with rapid lactate release. In contrast, lactate flooding of brain during physical activity or infusion provides an opportunistic, supplemental fuel. Available evidence indicates that lactate shuttling coupled to its local oxidation during activation is a small fraction of glucose oxidation. Developmental, experimental, and physiological context is critical for interpretation of metabolic studies in terms of theoretical models.

The frissonnant mutant mouse, a model of dopamino-sensitive, inherited motor syndrome

The frissonnant (fri) mutation is an autosomic recessive mutation which spontaneously appeared in the stock of C3H mice. fri mutant mice have locomotor instability and rapid tremor. Since tremor ceases when mutant mice have sleep or are anaesthetized, and because of their obvious stereotyped motor behavior, these mice could represent an inherited Parkinsonian syndrome. We show here that the fri/fri mouse fulfills two out of the three criteria required to validate an experimental model of human disease, that is isomorphism, homology and predictivity. Indeed, fri/fri mice present an important motor deficit accompanying visible tremor and stereotypies. They display some memory deficits as in human Parkinson's desease. l-Dopa and apomorphine (dopaminergic agonists), ropinirole (selective D2 agonist), and selegiline (an monoamino-oxidase B [MAO-B] inhibitor) improve their clinical status. However, neither anatomopathological evidence of nigrostriatal lesion, nor decrease in tyrosine hydroxylase production could be seen.

A comparison of glycogen phosphorylase a and cytochrome oxidase histochemical staining in rat brain

The utility of metabolic markers that index functional neuronal circuits is widely appreciated. The present study asks whether patterns of the metabolic enzyme, active glycogen phosphorylase, parallel those of the neuronal marker, cytochrome oxidase. Fresh frozen rat brain sections (30 microns) were processed for either active glycogen phosphorylase or cytochrome oxidase at each of ten levels of the neuraxis. Although these metabolic markers predominate in different cellular compartments--glycogen phosphorylase in the astrocytic compartment and cytochrome oxidase in the neuronal compartment--the patterns of high, moderate, and low levels of activity for both enzymes were generally parallel. These similarities extended to detailed patterns of heterogeneous staining within structures, in particular, to laminated and modular distribution within cerebral and cerebellar cortical structures. The modular distribution was evident in barrel structures in the cerebral cortex and in parasagittal compartments in the vermis of the cerebellum. Conspicuous differences between the two patterns occurred in white matter, in subcortical grey matter regions such as the nucleus accumbens, diagonal band, amygdala, and globus pallidus, and in the superior olivary nuclei of the brainstem as well as in nonneural structures such as the choroid plexus and ependyma. Discrete patchiness was characteristic of active glycogen phosphorylase distribution in the limbic neuropil of the dentate gyrus and entorhinal cortex. The strong parallels between active glycogen phosphorylase and cytochrome oxidase distribution support the view that glycogen phosphorylase, despite its glial localization, can reflect neuronal metabolic demands.